Thats right Eqz, but one substantial commercial deal could change all of that in a heart beat. What motivates me is that Jansen invited PIQ to join their clinical trial and the results have been positive. Jansen have an expensive new drug that is expensive, so they need to be able to justify the veracity of this expensive treatment. Only PIQ can demonstrate accurate predictive outcomes out to 4 years, so Jansen or their affiliate really need PIQ on board. l think its just a waiting game. They will move when it suits them, but move they will. All based on logic l am privy to.
Ann: Annual Report to shareholders, page-41
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.65M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 40.0¢ | 38.0¢ | $98.01K | 252.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9722 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 44999 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |